NasdaqGM - Delayed Quote USD
STAAR Surgical Company (STAA)
31.39 -1.95 (-5.85%)
At close: May 27 at 4:00:00 PM EDT
31.44 +0.05 (+0.16%)
Pre-Market: 8:16:56 AM EDT
Trade STAA on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreChart Range Bar
Loading chart for STAA
- Previous Close
33.34 - Open
33.23 - Bid 23.93 x 200
- Ask 39.85 x 200
- Day's Range
31.05 - 33.38 - 52 Week Range
15.59 - 35.87 - Volume
1,044,786 - Avg. Volume
1,198,073 - Market Cap (intraday)
1.563B - Beta (5Y Monthly) 1.20
- PE Ratio (TTM)
-- - EPS (TTM)
-0.42 - Earnings Date (est.) Aug 12, 2026
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
29.67
Recent News: STAA
View More
Performance Overview: STAA
Trailing total returns as of 5/27/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
STAA
35.95%
S&P 500 (^GSPC)
9.86%
1-Year Return
STAA
65.91%
S&P 500 (^GSPC)
27.00%
3-Year Return
STAA
47.50%
S&P 500 (^GSPC)
78.82%
5-Year Return
STAA
78.09%
S&P 500 (^GSPC)
79.02%
Earnings Trends: STAA
View MoreAnalyst Insights: STAA
View MoreStatistics: STAA
View MoreValuation Measures
As of 5/27/2026
Market Cap
1.56B
Enterprise Value
1.44B
Trailing P/E
--
Forward P/E
136.99
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.40
Price/Book (mrq)
4.43
Enterprise Value/Revenue
4.94
Enterprise Value/EBITDA
97.35
Financial Highlights
Profitability and Income Statement
Profit Margin
-7.24%
Return on Assets (ttm)
0.88%
Return on Equity (ttm)
-5.99%
Revenue (ttm)
290.38M
Net Income Avi to Common (ttm)
-21.03M
Diluted EPS (ttm)
-0.42
Balance Sheet and Cash Flow
Total Cash (mrq)
163.89M
Total Debt/Equity (mrq)
10.58%
Levered Free Cash Flow (ttm)
-17.51M
Compare To: STAA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Company Insights: STAA
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected. Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
Research Reports: STAA
View MoreRaising target price to $35.00
STAAR SURGICAL CO has an Investment Rating of HOLD; a target price of $35.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
RatingPrice TargetRaising target price to $34.00
STAAR SURGICAL CO has an Investment Rating of HOLD; a target price of $34.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
RatingPrice TargetRaising target price to $30.00
STAAR SURGICAL CO has an Investment Rating of HOLD; a target price of $30.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
RatingPrice TargetRaising target price to $29.00
STAAR SURGICAL CO has an Investment Rating of HOLD; a target price of $29.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
RatingPrice Target